Can protein vaccines for COVID-19 win over the vaccine-hesitant?

Click to increase image sizeClick to decrease image size

Declaration of interest

E Hammershaimb and T Milagritos are investigators for studies of COVID-19 vaccines developed by Novavax and Moderna for which their institution receives funding through the NIH but do not have a direct financial relationship with either company. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or material discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded.